Atara Biotherapeutics (ATRA) Tax Provisions (2013 - 2025)
Atara Biotherapeutics (ATRA) reported Tax Provisions of $28000.0 for Q3 2025, up 264.71% on a YoY basis from $7677.4 in Q3 2024, and up 833.33% quarter-over-quarter from $3000.0 in Q2 2025.
Atara Biotherapeutics (ATRA) Tax Provisions (2013 - 2025) Analysis & Trends
Atara Biotherapeutics has reported Tax Provisions for 13 years, with the latest figure at $28000.0 in Q3 2025.
- For the quarter ending Q3 2025, Tax Provisions rose 264.71% year-over-year to $28000.0; the trailing twelve-month figure through Mar 2026 stood at $31000.0 (up 186.11% YoY), and the FY2025 full-year result was $31000.0, up 358.33% from the prior year.
- Tax Provisions for Q3 2025 stood at $28000.0, up from $3000.0 in the prior quarter.
- The five-year high for Tax Provisions was $30000.0 in Q4 2021, with the low at -$19000.0 in Q3 2023.
- Historically, Tax Provisions has averaged $7076.9 across 5 years, with a median of $10000.0 in 2022.
- Annual changes were most pronounced in 2021 — Tax Provisions jumped 1500.0% — and 2023, when it sank 290.0%.
- Atara Biotherapeutics' Tax Provisions stood at $30000.0 in 2021, then plunged by 93.33% to $2000.0 in 2022, then soared by 450.0% to $11000.0 in 2023, then tumbled by 272.73% to -$19000.0 in 2024, then surged by 247.37% to $28000.0 in 2025.
- The last three Tax Provisions figures came in at $28000.0 (Q3 2025), $3000.0 (Q2 2025), and -$19000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Atara Biotherapeutics | 134.61 Mn | 126.21 Mn | 392,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 28,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | -19,000.00 |
| Sep 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 11,000.00 |
| Sep 30, 2023 | -19,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 22,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Dec 31, 2021 | 30,000.00 |
| Jun 30, 2021 | 16,000.00 |
| Dec 31, 2020 | 8,000.00 |
| Sep 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 1,000.00 |
| Dec 31, 2019 | 12,000.00 |
| Dec 31, 2018 | -47,000.00 |
| Jun 30, 2018 | 3,000.00 |
| Dec 31, 2017 | -16,000.00 |